Age-Related Sarcopenia
Conditions
Keywords
aged, inpatients, hand strength
Brief summary
It is recommended to screen ageing patients for sarcopenia, due to the increased risk of morbimortality if detected positive. According to the consensus of the European Working Group on Sarcopenia in Older People, the diagnosis of sarcopenia is based, among other things, on grip strength measurement. Our study will compare the performance of the new GRIPWISE digital device with the mechanical dynamometer JAMAR, the gold standard currently used to assess the grip strength. We propose to evaluate it in an elderly hospitalized population where the prevalence of sarcopenia is likely to be high due to the high prevalence of various chronic illness, notably oncological and cardiological ones. This cross-sectional study will include 348 patients.
Interventions
None listed
Sponsors
University Hospital, Caen
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* men and women aged 65 or over * affiliated to a health insurance * Francophone.
Exclusion criteria
* \- refusal to participate * unable to communicate * unable to use both hands (dominant and non-dominant)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Comparison between Jamar® and Gripwise® values for grip strength measurement | day1 | Intra-class correlation between the best values obtained with each device |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| comparison according to the patient's position | day1 | correlations of dynamometer measurements between patients assessed in the sitting or lying position |
| number of attempt to reach the maximum value | day1 | Comparison of the three measurements obtained for each patient with each device |
| factors influencing detected weakness | day1 | significant difference in the rate of women detected as weak with a handgrip \<16kg and men \<27kg, between the different reasons for hospitalisation, the number of days of hospitalisation, and between the different chronic cancerous and non-cancerous pathologies (Updated Charlson Comorbidity Index), the age groups 65-79 years and ≥80 years |
| satisfaction using the devices | day1 | rate of patients finding one of both device easier to use |
Countries
France
Outcome results
None listed